4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001415889-25-014477
Options or other derivatives
- Chief Medical Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Storgard Chris Chief Medical Officer | 2025-05-01 | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | D | ||
Loading xslF345X05/form4-05232025_080531.xml…